(Q37823382)

23 August 2017

1 reference

title

Surveillance of adverse effects following vaccination and safety of immunization programs (English)

1 reference

23 August 2017

0 references

1 reference

Francisco Luis Pimentel

1 reference

ORCID Public Data File 2021

author name string

Eliseu Alves Waldman

1

1 reference

23 August 2017

Karin Regina Luhm

2

1 reference

23 August 2017

Sandra Aparecida Moreira Gomes Monteiro

3

1 reference

23 August 2017

Fabiana Ramos Martin de Freitas

4

1 reference

23 August 2017

publication date

1 February 2011

1 reference

23 August 2017

published in

Revista de Saude Publica

1 reference

23 August 2017

volume

45

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

173-184

1 reference

Side-effects with Japanese encephalitis vaccine

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Vaccinology: past achievements, present roadblocks and future promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Paraná, Brazil, 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

The use of genomics in microbial vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Role of epidemiology in vaccine policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Epidemiologic methods in immunization programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Vaccine adverse events: causal or coincidental?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Vaccine risks: real, perceived and unknown

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Technologies that make administration of vaccines safer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

MMR mass vaccination campaigns, vaccine-related adverse events, and the limits of the decision making process, in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Identification and recall of children with chronic medical conditions for influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Active surveillance of vaccine safety: a system to detect early signs of adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Immunization safety priority project at the World Health Organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

A global perspective on vaccine safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

"Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Confounding in studies of adverse reactions to vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Adverse events following diphtheria, pertussis and tetanus vaccinations and factors associated with severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Impact of anti-vaccine movements on pertussis control: the untold story

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Vaccines and autism: a tale of shifting hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Study designs for evaluating different efficacy and effectiveness aspects of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Potential alterations in immunogenicity by combining or simultaneously administering vaccine components.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Measles outbreaks in a population with declining vaccine uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-mérieux sérums et vaccins

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

The Brighton Collaboration: enhancing comparability of vaccine safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Causal or casual? The role of causality assessment in pharmacovigilance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Surveillance for adverse events after DTwP/Hib vaccination in Brazil: sensitivity and factors associated with reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Use of an electronic monitoring system for self-reporting smallpox vaccine reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Patient experience with, and use of, an electronic monitoring system to assess vaccination responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Use of vaccine surveillance data in the evaluation of safety of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Interruption of measles transmission in Brazil, 2000-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Factors influencing vaccine uptake in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Evaluation of adverse effects of vaccines: the case-control approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Tracking mothers' attitudes to MMR immunisation 1996-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

21 January 2018

has goal

discusses the cited work

2 references

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

21 January 2018

Methodology data of "A qualitative and quantitative citation analysis toward retracted articles: a case of study"

Prevention and monitoring of adverse events following immunization: the “Green Channel” of the Veneto region in Italy

3 August 2024

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

Is Infant Immunization a Risk Factor for Childhood Asthma or Allergy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0034-89102011000100020

10.1590/S0034-89102011000100020

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference